Latest News

2026 ACMG Meeting - Baltimore - Where Genetics Meets Innovation

About the ACMG Annual Clinical Genetics Meeting

The American College of Medical Genetics and Genomics invites you to the 2026 Annual Clinical Genetics Meeting in Baltimore from March 10-14, 2026. Come and discover the latest research and innovative advances in clinical genetics, exchange ideas with colleagues and hear about new gene therapies.

One Retinoblastoma World 2026 - San Antonio, Texas

Welcome to One Rb World 2026, San Antonio, Texas
Saturday, September 12 – Monday, September 14, 2026

The 8th One Rb World Conference will take place immediately before the 58th World Congress of the International Society of Pediatric Oncology, which will be held in San Antonio, September 15-18, 2026.

Welcoming retinoblastoma patients, survivors, family members, medical professionals and scientists, we look forward to sharing three full days of One Rb World programming, community and collaboration in the Lone Star State.

One Rb World 2026 will be hosted by World Eye Cancer Hope USA, organized together with Jesse Berry M.D., Director of Ocular Oncology and Retinoblastoma at Children’s Hospital Los Angeles (CHLA); Patricia Chévez-Barrios, M.D., Director of Ophthalmic Pathology Residency Program and Professor of Pathology and Genomic Medicine at Houston Methodist Hospital in Texas; Maura Di Nicola M.D., Assistant Professor of Clinical Ophthalmology at Bascom Palmer Eye Institute in Miami, Florida; and Dan S. Gombos, M.D., Professor at the Department of Head and Neck Surgery in the Division of Surgery at the University of Texas MD Anderson Cancer Center in Houston, Texas.

We recognize our 2026 conference falls during Rosh Hashana, and we apologize for any conflicts this may create. We hope many in our community will still be able to participate, and we remain committed to making the conference as accessible and inclusive as possible.

ISGEDR 2027 - Where in the World?
Submissions Date extended until 31st January 2026

ISGEDR 2027 Meeting Host Application:

Offering to serve as host is a wonderful professional opportunity and also a tremendous effort. ISGEDR is always keen to partner and organize this meeting jointly with any national society focusing on genetics and/or retinoblastoma. Use the above QR code or use this direct link: https://forms.gle/rQ2tJ43SbCZS1A3b9
Submissions will be accepted until 31st January 2026 with Voting then opening up until 1st March 2026.

OGSC 2025 - Registration Still Open CLOSED

Registration fee: $60.00 Virtual – $100.00 In Person

'In Person’ registration fees will includes breakfast, lunch and coffee breaks. Registration linked HERE

OGSC 2025 - Final Program

Click on Image above to download Final Program

ISGEDR Joint Meeting - Oslo 2025 - Recordings Available

We are excited to announce the ISGEDR 2025 Oslo Recordings are available to Joint Meeting Delegates. Recordings will be available via a password-protected web page with access details being mailed to delegates directly. Access is until the end of 2025 with Protected PDFs of presentations being added where permitted.

DISCLAIMER: Presentations at the ISGEDR meeting are chosen by a meeting committee based on topics of interest to members. Content of presentations is the responsibility of each presenter and does not represent the opinions of ISGEDR.

Program

We are excited to announce the ISGEDR 2025 Oslo program!

This year’s meeting will feature a diverse and dynamic lineup of speakers and sessions, including the prestigious named lectures: the Franceschetti Lecture, Ellsworth Lecture, Judith Kingston Lecture, and François Lecture. The program also includes paper and poster sessions, cases, mini-symposiums, patient sessions, and the EURBG Business Meeting - all highlighting the latest developments in the field.

While most of the schedule is now available, a few details are still being finalised. We encourage you to check back regularly to download the most up-to-date version of the program.

We look forward to welcoming you to an engaging and inspiring meeting in Oslo!

Ocular Genetics Fellowship - Accepting Applications

Ocular Genetics Fellowship

We are accepting applications for one of our fully funded ocular genetics fellowship slots and welcome both national and international applicants. This would be for a July 1, 2026 start. Deadline for applications is end of August. Interested candidates can contact me directly alex_levin@urmc.rochester.edu. Please circulate this widely.

Thanks!

Alex V. Levin, MD, MHSc, FAAP, FAAO, FRCSC
Adeline Lutz - Steven S.T. Ching, M.D. Distinguished Professorship in Ophthalmology
Chief, Pediatric Ophthalmology and Ocular Genetics
Flaum Eye Institute
Chief, Clinical Genetics
Golisano Children’s Hospital and University of Rochester Medical Center

2025 OGSC Genetic Counselor Travel Stipend Application

The International Society of Genetic Eye Diseases is proud and excited to offer two genetic counselors a travel stipend in the amount of $1500 in order to attend the 2025 Ophthalmic Genetics Study Club to be held on Friday, October 17, 2025 in Orlando, FL. Please complete this application in its entirety if you are interested in being considered. Application deadline is Monday, August 25, 2025.

Scan the QR code above or use the Application Link HERE

Genetics of Ocular Development (GoOD) Meeting -
Ghent, Belgium, Monday 8 September - Tuesday 9 September, 2025

Genetics of Ocular Development (GoOD) Meeting

Dear colleagues,
We invite you to attend the upcoming Genetics of Ocular Development (GoOD) Meeting in Ghent, Belgium, Monday 8 September - Tuesday 9 September, 2025.
You can submit abstracts until Wednesday 16 July 17.00 CET, using the webform at the bottom of the meeting page or the abstract template attached HERE.
 
Topics of interest include:
          1. New eye development genes or mechanisms
          2. Diagnostics (clinical and molecular)
          3. Disease models (animal and iPSC-derived)
          4. Therapeutics
We are continuing to experience issues with our payment provider, but registration is fully available and you will be contacted regarding your payment. Early bird registration will be open until the 31st of August 2025.
 
Registration fees:
General registration members €180 (€205 after 31/8)
General registration non-members €300 (non-members) (€350 after 31/8)
Registration student members: €60 (€85 after 31/8)
Registration student non-members €120 (€170 after 31/8)
Networking event: €80
 
Invited lectures by Elena Semina, Juan Ramón Martínez-Morales & Alice Davidson.

We look forward to welcoming you to Ghent.

With best wishes, Elfride De Baere on behalf of the scientific committee: Nicola Ragge, Nicolas Chassaing, Patrick Calvas, Anne Slavotinek, Jean-Michel Rozet

Enquiries: contact Dorine Bax, email: dbax@brookes.ac.uk,  phone: 0044 (0) 1865 534923

OGSC 2025 Hybrid Meeting - Orlando, Florida – Registration Open

OGSC 2025 Hybrid Meeting

Friday, October 17, 2025

7:30 am to 5:00 pm.
Breakfast 7:30 am - Meeting begins 8:00 am

Rosen Plaza

Ballroom C, 9700 International Drive, Orlando, FL 32819

Ophthalmic Genetics Study Club 2024 - Group Photograph

By hakkun, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=59258209

Registration fee:

$60.00 Virtual
$100.00 In Person

'In Person’ registration fees will includes breakfast, lunch and coffee breaks.

Registration linked HERE

ABSTRACT SUBMISSIONS

Now accepting abstract submissions, DEADLINE is Monday, Sept 15, 2025
(reminder all abstracts accepted must be presented IN PERSON)

Ophthalmic Genetics Study Club 2025 – Abstract Submission

Now accepting abstract submissions, DEADLINE is Monday, Sept 15, 2025
(reminder all abstracts accepted must be presented IN PERSON)

Instructions and Notes:

Besides the outline information to be provided in the form below, please provide an Abstract  in PDF or Word format in the following Sections: Presenting Author, Email Address, Affiliation (to include Department, University, City and Country), Authors (maximum 10), Abstract Title, Paper Type, Purpose, Materials and Methods, Results, Conclusions.

All abstracts will undergo a peer-review process. Multiple abstracts may be submitted.

No Files ChosenAccepted file types: jpg, jpeg, jpe, gif, pdf, tar, zip, gz, gzip, rar, doc, xla, xls, xlt, xlw, docx, xlsx. Max. file size: 2 GB


The reCAPTCHA verification period has expired. Please reload the page.

OGSC 2025 Hybrid Meeting - Save the Date

Registration now open:

$100 for In Person  –  $60 for Virtual

OGSC 2025 Hybrid Meeting

Friday, October 17, 2025

7:30 am to 5:00 pm.
Breakfast 7:30 am - Meeting begins 8:00 am

Rosen Plaza

Ballroom C, 9700 International Drive, Orlando, FL 32819

Our venue for OGSC 2025 - Rosen Plaza, Orlando, Florida

ISGEDR Joint Meeting - Oslo 2025
Abstract Submissions Date Extended to 30 June - CLOSED

CLICK HERE TO SUBMIT ABSTRACT

Colleagues and Friends

We are pleased to announce the date for Abstract Submissions has been extended to the end of June. Click HERE to go directly to the Abstract Submission Form.

The ISGEDR2025 Organizing Committee

Josephine Prener Holtan, MD PhD, Local Lead Organizer and Program Chair
Prof. hon. Dr.med Francis L. Munier, President of ISGEDR
Bart P LEROY, MD, PhD, Executive Vice-President ISGEDR
Elias I TRABOULSI, MD, MEd, Treasurer ISGEDR
Prof. Ragnheidur Bragadottir, MD, PhD, Dept. of Ophthalmology, Oslo University Hospital

 

Call for Travel Grant Applications – ISGEDR 2025, Oslo - CLOSED

Call for Travel Grant Applications – ISGEDR 2025, Oslo - CLOSED

We are pleased to announce that applications are now open for travel grants to attend the upcoming ISGEDR meeting. There are three travel grants available, each covering the registration fee and a fixed sum of $1,500 to support travel and accommodation expenses.

Applications must be submitted by May 1st to Dr. Josephine Prener Holtan - jospre@ous-hf.no. Successful applicants will be notified by June 1st, 2025.

The application should include the following:

  • Name, academic affiliation and contact information, including street address, email address and telephone number.
  • Short motivation letter (max 1 page), describing your interest in attending the meeting of ISGEDR and how this attendance will benefit your clinical or research career
  • CV (max 2 pages)
  • Title and abstract of your submitted or planned contribution to the ISGEDR meeting

We will prioritize trainees, early-career researchers and applicants from underserved countries.

 ISGEDR 2025
Grant Review Committee

ISGEDR Joint Meeting - Oslo 2025 - LAUNCH

ISGEDR Joint Meeting, Sao Paulo 2023

Colleagues and Friends

We are pleased to announce the launch of registration and abstract submission for the ISGEDR2025 Meeting in Oslo, Norway. We invite you to join us for a collegial and informative scientific gathering of interested people from around the globe.

For more information, to register, or to submit an abstract, visit ISGEDR Joint Meeting - Oslo 2025 page

The ISGEDR2025 Organizing Committee

Josephine Prener Holtan, MD PhD, Local Lead Organizer and Program Chair
Prof. hon. Dr.med Francis L. Munier, President of ISGEDR
Bart P LEROY, MD, PhD, Executive Vice-President ISGEDR
Elias I TRABOULSI, MD, MEd, Treasurer ISGEDR
Prof. Ragnheidur Bragadottir, MD, PhD, Dept. of Ophthalmology, Oslo University Hospital

 

ISGEDR 2025 - Oslo Meeting - Save the Date!

The International Society of Genetic Eye Diseases & Retinoblastoma (ISGEDR) is excited to announce its biannual 2025 meeting, taking place September 11-13 in Oslo, Norway. Hosted by the Department of Ophthalmology, Oslo University Hospital, this event promises to be a landmark gathering for those passionate about ophthalmic genetics and retinoblastoma.

Building on the success of previous ISGEDR meetings in Lausanne (2021) and São Paulo (2023), the 2025 Oslo meeting will once again offer an expansive and dynamic platform to explore the latest advancements in the field.

Don’t miss the chance to be part of this extraordinary event – ISGEDR 2025 in Oslo awaits!

ISGEDR 2025 - Oslo

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

ISGEDR Membership Renewal

ISGEDR Joint Meeting, Sao Paulo 2023

Dear Colleagues

It is the time of the year to renew your membership to your Society! Our dues have remained the same for more than a decade now. Remember they are assessed by Calendar year. We are in the thick of preparations for a wonderful meeting in Oslo this September and you will benefit from a reduced registration rate. Our Journal "Ophthalmic Genetics" is provided to you in electronic format as a benefit to your membership. Go to ISGEDR Membership and renew your membership for 2025!

Kindest regards from our Executive Committee

Francis Munier, President
Bart Leroy, Executive VP
Elias I. Traboulsi, Secretary-Treasurer
Brian Brooks, Member-at-Large
Meghan DeBenedictis, Member-at-Large
Arlene Drack, Member-at-Large
Arif Khan, Member-at-Large
Alex Levin, Member-at-Large
Birgit Lorenz, Immediate Past-President

ISGEDR Joint Meeting, Giessen 2019

Happy New Year 2025

Dear Colleague

We write to wish you a Happy New Year 2025, full of good health, professional and personal fulfillment. We invite you to renew your membership or to join if you are not currently a dues-paying full member of the Society. Dues apply to the year in which they are paid so we recommend you complete the process early in January.

Benefits of membership include a free online subscription to Ophthalmic Genetics, the official publication of ISGEDR, and a reduced rate to attend the bi-yearly meeting. Dues help us sustain and expand the organization.

You are our ambassadors! Please encourage colleagues to join. We welcome physicians, scientists and genetic counselors with interest in our fields.

We are in the midst of preparing for the September 11-13, 2025 meeting in Oslo, Norway and we look forward to seeing you there.

For more information and to fill-out your membership form click here

Kindest regards from our Executive Committee

Francis Munier, President
Bart Leroy, Executive VP
Elias I. Traboulsi, Secretary-Treasurer
Brian Brooks, Member-at-Large
Meghan DeBenedictis, Member-at-Large
Arlene Drack, Member-at-Large
Arif Khan, Member-at-Large
Alex Levin, Member-at-Large
Birgit Lorenz, Immediate Past-President

Call for papers for Gal Festschrift

Fellow ISGEDR Members and Friends in the Ophthalmic Genetics Community

As many of you know, after many years of dedicated service, our friend and colleague, Prof. Andreas Gal has recently stepped down from his leadership position on the Editorial Board of Ophthalmic Genetics. Andreas has been a major force in our field , making seminal contributions in several areas and diseases including Norrie disease, Fabry disease, Usher syndrome and RPE65, RDH12, Peripherin/RDS and MERTK-related retinal dystrophies. Perhaps just as importantly, Andreas has had a real heart for our journal and has helped tremendously in making the publication what it is today. We want to honor him with a special Festschrift issue of Ophthalmic Genetics to be published in the second half of 2025 and invite you to contribute an article to this issue. Articles that deal with conditions where Andreas was a key player are most welcome, but, given the breadth of his contributions, any quality article that would be an honor to him will be highly considered.

We will be working with Taylor and Francis to expedite the review and publication of articles designated for this issue. Please let us know by return email if you are able to submit a paper to this Special issue of your Journal.

Many thanks for considering this and we look forward to seeing you at our upcoming meeting in Norway in 2025.

Best wishes,

Brian Brooks, Editor-in-Chief, Ophthalmic Genetics - brooksb@nei.nih.gov
Elias I. Traboulsi, Editor Emeritus, Ophthalmic Genetics - TRABOUE@ccf.org

Ophthalmic Genetics Study Club 2024 - Group Photograph

ISGEDR 2025 - Oslo

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Join us in Oslo for the ISGEDR 2025 Meeting!

The International Society of Genetic Eye Diseases & Retinoblastoma (ISGEDR) is excited to announce its biannual 2025 meeting, taking place September 11-13 in Oslo, Norway. Hosted by the Department of Ophthalmology, Oslo University Hospital, this event promises to be a landmark gathering for those passionate about ophthalmic genetics and retinoblastoma.

Building on the success of previous ISGEDR meetings in Lausanne (2021) and São Paulo (2023), the 2025 Oslo meeting will once again offer an expansive and dynamic platform to explore the latest advancements in the field.

Topics to be addressed over a fascinating three-day meeting include clinical and molecular diagnosis, management and treatment of inherited ocular developmental conditions, genetic syndromes involving the eye, inherited retinal dystrophies as well as retinoblastoma.

Three leading international experts will share their experience and insights in the Ellsworth, Franceschetti and François Keynote Lectures. The program will highlight clinical, molecular and therapeutic innovations and will provide insight from the World’s best experts including clinicians, scientists, patients, regulators as well as industry representatives.

It promises to be a gathering to foster collaborations, inspire the next generation and build and extend one’s professional network in the field of ophthalmic genetics and retinoblastoma. Whether you are a seasoned expert, an emerging researcher, a patient advocate, or an industry leader, ISGEDR 2025 will provide invaluable opportunities to foster collaboration, inspire the next generation, and broaden your professional network in ophthalmic genetics and retinoblastoma.

And as the cherry on the cake, the stunning city of Oslo will provide the perfect backdrop to science at ISGEDR 2025. From its rich heritage and culture to its amazing natural surroundings and views, the city will provide both participants and their partners the ideal social events and accommodation for a fruitful meeting.

Don’t miss the chance to be part of this extraordinary event – ISGEDR 2025 in Oslo awaits!

ISGEDR 2025 - Oslo

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Ophthalmic Genetics Study Club 2024 – Chicago Hybrid Meeting

Thursday, October 17  –  Ann & Robert H. Lurie Children’s Hospital of Chicago

OGSC 2024 – Final Program

Moderators: Elias I. Traboulsi & Virginia M. Utz

Session 1

Schedule

Title

Presenter

7:00 Breakfast/Catching up
7:25 Welcome Elias I. Traboulsi, MD, MEd
Cleveland Clinic Cole Eye Institute
Virginia Utz, MD
Cincinnati Children’s Hospital Medical Center
7:30 Awardee Presentation
“MORC2-related Neurodevelopmental and Neuropathy Spectrum Disorder and Klinefelter syndrome: Genetic and Ocular Findings”
Rebecca Procopio, MS, CGC
Wills Eye Hospital
7:45 RPE65 Update:
– Safety and Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 8 and 9 Years
– Genetic epidemiology of RPE65-mediated inherited retinal disease in the United States
David L. Rousso, Ph.D
Aditya Saxena, Ph.D
Spark Therapeutics, Inc.
8:05 The Long and Short of it: Expanding the Phenotype and Ocular Manifestations of Neurofibromatosis 1 Microdeletion Syndrome Janice Lasky Zeid, M.D.
Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University
8:20 Pars Plana Vitrectomy in Congenital X-Linked Retinoschisis Nieraj Jain, M.D.
Department of Ophthalmology, Emory University School of Medicine
8:35 Could Estrogen reduce the Split? Kimerly Stepien
MD University of WI- Madision Department of Ophthalmology and Visual Sciences
8:50 Ophthalmological Manifestations in a Pediatric Population with Stickler Syndrome Types I and II Andy Drackley, MS, CGC
Lurie Children’s Hospital of Chicago
9:05 Macular dystrophy, what is the missing puzzle piece? Fyqah Almahmoudi, MD
King Fahd Armed Forces Hospital, Saudi Arabia
9:20 Coffee Break

Session 2

Schedule

Title 

Presenter

9:40 Genetic Basis for Bilateral Optic Atrophy, Bilateral Medial Rectus Hypoplasia, Oligophrenia and Stroke in 31 y/o Male Patrick J. Droste MS, MD
Pediatric Ophthalmology PC
9:55 Phenotypic variability of MAF-Associated Congenital Cataracts: Isolated or Syndromic? Jennifer Rossen, MD
Lurie Children’s Hospital of Chicago
10:10 Awardee Presentation
“Compound Heterozygous Nonsense and Frameshift Mutations in Exon 43 of EYS Causing Reduced Penetrance”
Megan Soucy, MS, CGC
Columbia University – Department of Ophthalmology
10:25 Genotypic and Phenotypic Expansion of ADAMTS18-Related Ocular Pathology Ari August, MD
Wills Eye Hospital
10:40 Genetic variants in patients with bilateral congenital cataracts in a large cohort from North India Savleen Kaur, MD, DNB, FICO, FAICO
Post Graduate Institute of Medical Education and Research, India
10:55 Lessons learned from the ClinGen Gene and Variant Curation Expert Panels Lev Prasov, MD, PhD
University of Michigan
11:10 Macular scars from prior ocular toxoplasmosis infection? Arif Khan, MD
Cleveland Clinic Abu Dhabi
11:25 Compound heterozygous CYP1B1 variants in juvenile open angle glaucoma (JOAG) Brenda L. Bohnsack, MD, PhD
Ann & Robert H. Lurie Children’s Hospital of Chicago
11:40 INTS11 neurodevelopmental disorder with electronegative ERG Monique Leys, MD
WVU Eye Institute
11:55 Lunch Break  

Session 3

Schedule

Title

Presenter

12:40 Tribute to Frank Judisch, MD Arlene Drack, MD
University of Iowa
12:50 Distinguished Special Lecture
“Saturday Night FEVR and Three Decades of Research in Maritime Canada”
Johane Robitaille, MD
13:40 Thirty-year follow-up of surgical repair of congenital ectopia lentis including DNA analysis Irene H Maumenee, MD
CUIMC/Edward S. Harkness Eye Institute
13:55 Homozygous deletion in P-CARE results in a maculopathy and cone-rod dystrophy Ian MacDonald, MSc, MD, CM
University of Montreal 
14:10 Pigmentary retinopathy and optic disc swelling in siblings with ABCA4 mutations Scott Brodie, MD, PhD
Columbia University Vagelos College of Physicians and Surgeons
14:25 Association of colobomas with variants in the Rho family of small GTPases and effector genes Diana Brightman, PhD, MS
Cincinnati Children’s Hospital Medical Center 
14:40 Amblyopia Not Responding to Treatment Alina Dumitrescu, MD
University of Iowa 
14:55 Microcephaly and chorioretinopathy in a child born to an Ophthalmology resident: perspectives as a doctor and mother in training Emily Levine, MD
Dartmouth Hitchcock Medical Center 
15:10 Coffee Break  

Session 4

Schedule

Title

Presenter

15:30 Results of the first patient-customized intravitreally-administered antisense oligonucleotide (ASO) for a patient with retinal dystrophy caused by an intronic pseudogene Emily McCourt, MD
University of Colorado
15:45 A case of fish-eye disease caused by novel variants in LCAT Matt Benson, MD
University of Alberta
16:00 Deep phenotyping reveals novel ophthalmic findings in Smith-Lemli-Optiz Syndrome Kati Veres, MD
National Eye Institute/NIH
16:15
Case Presentation
Noor Ghali, M.S.
Case Western Reserve University SOM
16:30 Ellipsoid zone optical gap and cone-rod dystrophy secondary to ABCA4 p.Pro143Leu variant Kirill Zaslavsky
Massachusetts Eye and Ear Infirmary
16.45 Ultracompact hand-held swept source optical coherence tomography (SS-HH-OCT) as a novel diagnostic modality for early-onset retinal dystrophies (EORDS) Ramiro Maldonado, MD
Duke Eye Center
17:00
Presentation
Dan Chung, DO
SparingVision
if time permits Case Presentation Scott Brodie, MD, PhD
Columbia University Vagelos College of Physicians and Surgeons
Concluding Remarks / Adjourn
OGSC Business Meeting

OGSC 2024 - Travel Award Winners

Rebecca Procopio - Wills Eye Hospital

Megan Soucy - Columbia University Medical Center

ISGEDR is pleased to announce two genetic counselors have been awarded a travel award for this year's OGSC conference:

Rebecca Procopio of Wills Eye Hospital presenting MORC2-related Neurodevelopmental and Neuropathy Spectrum Disorder and Klinefelter syndrome: Genetic and Ocular Findings.

Megan Soucy of Columbia University Medical Center Ophthalmology Department presenting Compound Heterozygous Nonsense and Frameshift Mutations in Exon 43 of EYS Causing Reduced Penetrance.

University of Iowa - Clinical Pediatric Ophthalmic Genetic Fellowship

 

The University of Iowa Department of Ophthalmology & Visual Sciences offers a 1-year clinical pediatric ophthalmic genetic fellowship.

This sub-specialty fellowship is under the mentorship of Arlene Drack, MD, and Alina Dumitrescu, MD and includes active, full-time participation in all aspects of the clinical and research programs of the pediatric ophthalmic genetic service. The Fellow will work closely with the attendings, genetic counselor, and the Pediatric Ophthalmology Fellow and will have some shared responsibilities. We are a very busy service and see a comprehensive range of pathology that includes inherited retinal disorders, congenital ocular malformations, genetic syndromes, and metabolic diseases that affect the eye.

The Fellow will participate in all pediatric ophthalmic genetics clinics and inpatient consultations. The fellow will have dedicated time for training in electrophysiology. The electrophysiology service has equipment and expertise in all necessary testing including ERG, VEP, FST, and dark adaptometry in awake patients and under anesthesia. At the end of their Fellowship, the ophthalmic genetic Fellow will be experienced in performing and interpreting a broad range of electrophysiology testing.

The Fellow will have the opportunity to participate in the full range of additional didactic and other educational activities, including weekly Medical Genetic conferences with the Division of Medical Genetics, Stone Rounds, daily Ophthalmology Department morning rounds, and weekly didactic post-clinic teaching together with residents and orthoptic students. The Fellowship includes attending one external genetics conference, usually the Ophthalmic Genetics Study Club, with an accepted presentation. The Fellow is also expected to teach medical students and residents who rotate through the Pediatric Ocular Genetics service. The Fellow will present in pediatric genetics case rounds, ocular genetics team meetings, genetics journal clubs, and multidisciplinary genetics conferences.

Research is an integral part of the ocular genetics fellowship, and opportunities range from bench laboratory in the Drack Lab to clinical research and participation as an investigator in clinical trials. Prospective studies involving new diagnostic tools and therapies are always ongoing. Our faculty are investigators in human gene therapy trials. Ocular Genetics Fellows are expected to complete a research project and are encouraged to submit their research papers to local/national/international ophthalmology/ocular genetics meetings.

We have a faculty of 2 genetic eye disease-fellowship trained pediatric faculty who collaborate with colleagues in retina, cornea, glaucoma, neuro-ophthalmology, medical genetics and other specialties and have the resources of the University of Iowa Institute for Vision Research.

2024 OGSC Genetic Counselor Travel Stipend Application

The International Society of Genetic Eye Diseases is proud and excited to offer two genetic counselors a travel stipend in the amount of $1500 in order to attend the 2024 Ophthalmic Genetics Study Club to be held on Thursday, October 17, 2024 in Chicago, IL. Please complete this application in its entirety if you are interested in being considered. The deadline to apply is Friday, August 30, 2024.

Scan the QR code above or use the Application Link HERE

ISOO Goa 2024 Congress – Save the Date

Dear Esteemed Colleagues, Distinguished Guests, and Participants, 

Namaste!

It is with immense pleasure and great enthusiasm that I extend a heartfelt welcome to each one of you to the International Society of Ocular Oncology (ISOO) Biennial Conference 2024 in the captivating realm of Goa, India. As the Congress President, it is both an honor and a privilege to host this esteemed gathering of experts, researchers, and professionals dedicated to advancing the field of ophthalmic oncology.

Our conference, set against the backdrop of the serene beaches and rich cultural heritage of Goa, promises to be a melting pot of knowledge, innovation, and collaboration. Let us together, explore the latest advancements, share ground-breaking research, and engage in meaningful discussions that will undoubtedly shape the future of our field.

We are poised to explore cutting-edge research, engage in thought provoking discussions, and foster connections that transcend geographical boundaries. The scientific activities will be offering a unique opportunity to deepen our understanding and push the boundaries in research and practice pattern.

Beyond the academic activities, I encourage you to take full advantage of the unique cultural experiences that Goa and India has to offer. Let us come together not only to enrich our professional lives but also to forge lasting connections, friendships, and live life to the fullest. As you step into the coastal paradise, be ready to explore the sun kissed beaches, lively markets to the historic Portuguese charm of Goa, every corner has a story to tell.

We look forward to fruitful discussions, collaborative discoveries, and the shared joy of being part of ISOO 2024. Wishing you all a memorable and rewarding experience against the backdrop of Goa’s warmth and hospitality.

Warm regards
Dr. Fairooz P. Manjandavida, MS, FRCOphth, FACS
Congress President ISOO 2024

ISOO Goa 2024 Website Linked HERE

 

OGSC 2024 Hybrid Meeting – Save the Date

By hakkun, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=59258209

OGSC 2024 Hybrid Meeting

Thursday, October 17, 2024
7:00 am to 5:00 pm.
Ann & Robert H. Lurie Children’s Hospital of Chicago
225 E. Chicago Ave, Box 70
Chicago, IL 60611-2991

Registration fee:
$60.00 Virtual
$100.00 In Person
‘In Person’ registration fees will includes breakfast, lunch and coffee breaks. Registration linked HERE

Visit Oslo – Your guide to Oslo

GoOD Meeting 2024 - Save the Date

Dear ISGEDR Members,

Building on the success of the last four Genetics of Ocular Development (GoOD) meetings, we are very pleased to announce that the 2024 meeting will take place from:

Monday 23rd September (arrival), with the main meeting days on the 24 - 25th September 2024 at New College, Oxford, UK.

New College, part of the University of Oxford, was founded in 1379 by William of Wykeham, Bishop of Winchester, and is steeped in historical, academic, and architectural excellence. The college was designed with cloisters and a bell tower and boasts the first enclosed quadrangle of its type, completed in 1386, with the original City Walls coursing through; all remain essential parts of college life today.

The conference itself will be located in a brand new architecturally stunning building Gradel Quad, New College, Oxford located adjacent to the main part of the College, which houses a beautiful lecture hall and new en-suite accommodation available to book, right in the heart of Oxford. A formal Dinner will be held in the historic Hall at New College.

The GoOD Meeting 2024 presents a fantastic opportunity for scientists and clinicians involved in the genetic research into eye anomalies, therapeutics and patient care to hear about the developments in the field of ocular genetics, learn of the latest research findings, meet with collaborators, establish new research opportunities and collaborations.

More details to follow soon.

Professor Nicola Ragge - Scientific Organiser and host
Professor Patrick Calvas - Scientific Organiser
Dr Nicolas Chassaing - Scientific Organiser

Countdown begins to ISGEDR Meeting 2025 Oslo

Dear ISGEDR Member

As you remember, we invited you and all members in good standing to vote on the location of the 2025 meeting. There were three excellent and attractive proposals: AbuDhabi, Oslo and Pittsburgh.

There was an overwhelming majority that supported holding the meeting in Oslo.

The Meeting dates have been set to September 11-13, 2025. The meeting Chair and Hostess will be Dr. Josephine Prener Holtan from Oslo University Hospital.

More details will follow.

Thank you for your continued support of the Society.

Bart P. Leroy and Elias I. Traboulsi

 

OGSC 2023 Hybrid Meeting - Program Available

View the latest Program for OGSC 2023 via this quick Program Link

Are you eligible for our $75 Discount Voucher Code?

If you are a Student, Fellow or practice in one of the United Nations Least Developed Countries then you can apply for a $75 Voucher Code.

Simply ask your supervisor to document your location, trainee or student status to Elias at TRABOUE@ccf.org

Ophthalmic Genetics Study Club (OGSC)
Hybrid Meeting – Friday, November 3rd, 2023

Dear Colleagues

Please join us for another fabulous OGSC hybrid meeting before the AAO meeting in San Francisco!

Ophthalmic Genetics Study Club (OGSC)

The meeting is in Gallery 1
Hyatt Regency San Francisco Downtown SOMA

Hybrid Meeting – Friday, November 3, 2023
7:00 am to 5:00 pm

Hyatt Regency San Francisco Downtown Soma

 

The registration fee will be slightly higher than previous years because of the associated expenses with securing an assigned venue through AAO, we have to charge a registration fee to cover expenses. The fees are:

In-Person: $150.00
Virtual: $75.00

‘In Person’ registration fees will includes a Brunch and Coffee breaks.

The Yearly Distinguished Special Lecture will be given by Dr. Arif Khan from
Cleveland Clinic Abu Dhabi. The title of his presentation will be:
“Inherited eye disease: lessons I have learned on the Arabian Peninsula”

São Paulo Webinars available NOW

International Council of Ophthalmology Invitation to World Ophthalmology Congress (WOC2024)

International Council of Ophthalmology
Invitation to World Ophthalmology Congress (WOC2024)

Fellowship in Ocular Genetics University of Rochester Flaum Eye Institute

Fellowship in Ocular Genetics:
University of Rochester Flaum Eye Institute

Fellowship in Ocular Genetics: University of Rochester Flaum Eye Institute

 

This Flaum Eye Institute Ocular Genetics Fellowship offers TWO (2) one-year funded positions.

The Director of the Fellowship Program is Dr. Alex V. Levin, Chief, Pediatric Ophthalmology and Ocular Genetics at the Flaum Eye Institute and Chief, Clinical Genetics at the University of Rochester Medical Center.

This sub-specialty fellowship will include active, full-time participation in all aspects of Ocular Genetics. The Fellows will work closely with Dr. Levin and our other ocular geneticist and ocular oncologist, Dr. Vikas Khetan, our 2 ocular genetic counselors and our residents, and the Pediatric Ophthalmology Fellow. We are very busy and see an enormous range of pathology in both adults and children, which includes inherited retinal degenerations, congenital ocular malformations, genetic syndromes, and metabolic diseases that affect the eye.

The year will include rotations in pediatric genetics, craniofacial, and metabolics clinics at Golisano Children’s Hospital as well as participation with Drs. Levin/Khetan and the clinical geneticists in inpatient consultations. The fellow will participate in multidisciplinary clinical genetics case rounds, ocular genetics team meetings, and ocular genetics journal clubs. Laboratory experience is provided where the fellow will have exposure to DNA extraction, karyotyping, microarray analysis, sequencing and other molecular techniques.

The Fellow will have the opportunity to participate in the full range of additional didactic and other educational activities at the Flaum Eye Institute and Golisano Children’s Hospital, including two ocular genetics course taught remotely to LV Prasad Eye Institute (India), resident lecture series, Dr. Edwin Stone‘s retinal dystrophy rounds, grand rounds, and didactic resident teaching. The Fellowship includes support to attend one external genetics conference. The Fellow is also expected to be involved with teaching medical students and residents who rotate through the Ocular Genetics service.

Research is an important part of the ocular genetics fellowship and opportunities range from bench laboratory to clinical research. Prospective studies involving new diagnostic tools and therapies are always ongoing. We are an approved site for Luxturna delivery and are involved in several gene therapy trials as well as work in stem cell and gene agnostic treatments. Ocular Genetics Fellows are expected to write and submit at least two manuscripts and are encouraged to submit their research to local/national/international ophthalmology/ocular genetics meetings.

As part of the Ocular Genetics team, the Fellow’s responsibilities include administrative and other supportive duties.

 

Requirements:

Candidates must have completed their general ophthalmology training or be senior house officers. Candidates ineligible for a license will be welcomed as observers with much clinical exposure and involvement under supervision, and receive full credit for the fellowship year. USMLE is not required.
If you are interested in our Ocular Genetics Fellowship Program, please complete and return the following:

A maximum one-page personal statement as to why you want to do this fellowship and what you plan to do with the training once finished. Preference is given to applicants who have future plans as an ocular geneticist and a position in advance to do so. If you have such a position, please also send a letter confirming this from your future Chair/Employer.
Photocopy of your certificate of registration/medical license.
Current curriculum vitae
Photograph of yourself (not required)
If you have previously published papers (not required), a copy of the 1-2 publications you are most proud of
Three letters of recommendation. The recommendation letters must also be sent as hard copy on original letterhead with original signature.
All documents should be sent electronically to Dr. Levin at least 6 months prior to the desired start date.

Only completed applications will be considered for interviews (offered by phone/zoom if not available to attend in person). Formal language testing is not required.

 

For more information, please contact:

Alex V. Levin, MD, MHSc, FAAP, FAAO, FRCSC
Adeline Lutz – Steven S.T. Ching, M.D. Distinguished Professorship in Ophthalmology
Chief, Pediatric Ophthalmology and Ocular Genetics
Flaum Eye Institute
Chief, Clinical Genetics
University of Rochester Medical Center
601 Elmwood Avenue, Box 659
Rochester, NY 14642
Phone 585-276-3560     Fax 585-276-2517     alex_levin@urmc.rochester.edu

 

NIH – National Eye Institute: Postdoctoral Fellowship in Genetics and Modeling of Developmental Eye Diseases

NIH – National Eye Institute:
Postdoctoral Fellowship in Genetics and Modeling of Developmental Eye Diseases

Postdoctoral Fellowship in Genetics and Modeling of Developmental Eye Diseases

A postdoctoral position is available immediately in the Pediatric, Developmental & Genetic Ophthalmology Section (https://www.nei.nih.gov/PDGO section) of the Ophthalmic Genetics and Visual Function Branch, NEI, National Institutes of Health (NIH), located in Bethesda, Maryland. The laboratory, headed by Dr. Brian Brooks, seeks to understand the genetic, molecular and developmental basis of inherited eye diseases such as uveal coloboma and oculocutaneous albinism that affect children. We focus on the molecular and cellular basis of optic fissure closure and retinal pigment epithelium (RPE) development with the aim to develop novel therapeutic approaches for these conditions.

This position offers exposure to multidisciplinary and cutting-edge developmental and stem cell research, and opportunities to collaborate closely with experts in genetics and translational research. The candidate will be leading/co-leading projects, designing experiments for investigating in vitro and in vivo models of disease, testing gene replacement and CRISPR-based gene editing approaches while working closely with collaborators and lab members. Opportunities for training in animal microsurgery as well as mentoring postbacs or summer students will be available based on interest.

Qualifications:
•   Candidates must hold a Ph.D. or M.D./Ph.D. in cell biology, genetics, neuroscience, development or a related field, with less than 4 years since completion of their final degree;
•   Must have first authorship on at least one peer-reviewed publication;
•   Must be self-motivated and keen to develop and/or learn cutting-edge technologies;
•   Experience in stem cell manipulation and/or mouse and/or zebrafish genetics is a plus;
•   The ability to work as part of a cohesive group is important as we are a highly collaborative lab;
•   Must have excellent writing and communication skills.
•   Salary will be commensurate with education and experience. The position provides generous scientific resources, stipend support, and health benefits. U.S. citizens, U.S. permanent residents, and non-U.S. citizens are eligible to apply. Women and underrepresented minorities are particularly encouraged to apply.

To Apply:
Interested candidates should send an email with cover letter, curriculum vitae, bibliography, a paragraph of research goals and interests and contact information of three references to: Dr. Uma Neelathi (uma.neelathi@nih.gov).

For further information about working at the NIH, visit: https://jobs.nih.gov

The NIH is dedicated to building a diverse community in its training and employment programs. DHHS, NIH, and NEI are Equal Opportunity Employers.

ISGEDR Meeting 2023 - SÃO PAULO, July 6-8, 2023

ISGEDR Meeting – Genetic Counselors:
ISGEDR Meeting 2023 – Genetic Counselors

IMPORTANT NOTE:

We have just added to the Registration Categories and Fees the category ‘Genetic Counselors’
to view the Fees please CLICK HERE

ISGEDR Meeting – São Paulo, Brazil 2023

ISGEDR Meeting 2023 – SÃO PAULO, July 6-8, 2023

It is the distinct pleasure of the International Society for Genetic Eye Diseases and Retinoblastoma to invite you all to São Paulo for the ISGEDR 2023 MEETING

For the first time in South America, our biannual meeting will take place from July 6th to 8th, 2023 in cosmopolitan São Paulo, Brazil, at CUBO, Latin America’s biggest innovation, health tech startups and entrepreneurship hub.

Considering the success of the hybrid format of the 2021 ISGEDR meeting in Lausanne, the organizing and executive committees chose the same format for 2023.

We are delighted to announce the following named Lectureship presenters:

Michael Gorin, MD, PhD – The Franceschetti Lecturer
Professor David Cobrinik, MD, PhD – The Ellsworth Lecturer
Professor Frans Cremers, MD, PhD – The François Lecturer

Together with expert international speakers who will participate in the meeting, the attendees will have the chance to interact with clinicians and scientists who have whose research and/or clinical practice center on the diagnosis and management of patients with ophthalmic genetic disorders and retinoblastoma.

Please join us!

Juliana M Ferraz Sallum, MD, PhD   President – ISGEDR MEETING 2023

São Paulo, Brazil 2023 – Link to Meeting Registration

StoneRounds - web-based Inherited Retinal Diseases resource

StoneRounds:
web-based Inherited Retinal Diseases resource

StoneRounds is a web-based resource (www.stonerounds.org) for improving your knowledge of inherited retinal diseases.  

It consists of an atlas of over 300 molecularly-confirmed cases, a “clinic simulator” in which you can pit your diagnostic skills against the computer (and get constructive feedback if you are wrong), some basic tutorials for beginners, and even a section of career advice for physicians and scientists (Success Camp).  The case content of StoneRounds also serves as the basis for live, Zoom-based clinical teaching sessions that anyone with an interest in inherited retinal disease is welcome to attend.  These teaching sessions are 60-90 minutes in length and are held an average of 4 times per month.  

The schedule for the live sessions can be found at: https://stonerounds.org/teaching/schedule.  If you create a (free) account on the website you can choose to be reminded about upcoming sessions by email.

CALL FOR PAPERS – Inherited Retinal Disease and Gene Therapy

CALL FOR PAPERS:
Inherited Retinal Disease and Gene Therapy

CALL FOR PAPERS – Inherited Retinal Disease and Gene Therapy
The Saudi Journal of Ophthalmology (SJOPT), a peer reviewed quarterly publication in the field of ophthalmology, is planning a special/theme-based issue on Inherited Retinal Disease and Gene Therapy to be published in October-December 2023. Submission of review articles, original articles, and cases reports for consideration are welcome.
Published in collaboration with Wolters & Kluwer/Medknow, SJOPT is the official publication of Saudi Ophthalmological Society (SOS). It is indexed with PubMed, SCOPUS, and Emerging Sources Citation Index (an off shoot of ISI).
Please note that SJOPT does not charge authors for publishing articles and complete on-line access to articles is free.
General author guidelines:
The abstract should not be more than 250 words (unstructured for Review Article and structured for Original Article) with 4-5 keywords
Article format:
a) Title/First Page to include main title, running title, authors in order of their appearance and their affiliations, source(s) of support, acknowledgement, declarations, (if any), full details of the corresponding author
b) Review Article: Main and running title, unstructured abstract, keywords, Introduction followed by the section titles depending upon the topic being reviewed with a Conclusion section at the end, References, Legends to figures and tables (if any)
c) Original Article:  Main and running title, structured abstract (purpose, methods, results and conclusion), keywords, Introduction, Methods, Results, Discussion, Conclusion, References, Legends to figures and tables (if any)
The manuscript should be approximately 3500-4000 words excluding abstract and references.
Figures/Tables: Total number of figures and tables not to exceed 8. Figures to be preferably in color
Manuscripts are to be submitted online [https://review.jow.medknow.com/SJOPT]
At the time of submission, kindly select “Inherited Retinal Disease and Gene Therapy” as Manuscript Type from the drop-down menu.
The deadline for receiving the submission is July 4, 2023. The manuscript acceptance will be subject to the review by the guest editor and/or editorial board members.
Best wishes
Arif O. Khan MDCleveland Clinic Abu Dhabi, UAE
Guest Editor, SJOPT; sjo.editor@gmail.com

NIH K12 Vision Scientist Program Inherited Retinal Degeneration Fellowship

NIH K12 Vision Scientist Program:
Inherited Retinal Degeneration Fellowship

NIH K12 Vision Scientist Program. Inherited Retinal Degeneration Fellowship.

University of Pennsylvania

Department of Ophthalmology, Scheie Eye Institute

This fellowship is open only to US residents or citizens. Senior residents or subspecialty fellows who are finishing their training in June 2024 and available to start the fellowship in July or early August 2024 can apply. Ophthalmologists who are already in clinical practice are also eligible. This fellowship will have a focus on translational clinical-research and clinical exposure to the diagnosis and management of genetic eye diseases at the Retinal Degeneration Centers of the Scheie Eye Institute and The Children’s Hospital of Philadelphia.

The fellowship can be supported by a K12 grant from the NIH/NEI. The candidate will be assessed by the K12 Program of the Dept. of Ophthalmology of the University of Pennsylvania. Acceptance will depend on availability of a slot and the candidates’ qualifications. The recipient will receive a salary and benefits at a PGY5 level of training. The fellow must be eligible for a full Pennsylvania license to practice medicine. K12 Scholars are permitted to spend up to 25% of their effort in patient care. The other 75% is for research that could involve seeing research patients or doing bench research.

Interested physicians who chose to forgo involvement in direct patient care can still apply to the K12 program directly for a retinal degeneration research fellowship without a deadline. Similarly, this is a competitive fellowship position that depends on the availability of a position through the K12 program and on the qualifications of the candidate.

Please contact Dr. Tomas S. Aleman directly for additional information at aleman@pennmedicine.upenn.edu.

ISGEDR and the Scientific Community at Large Mourn the Loss of Dr Samuel Jacobson

ISGEDR and the Scientific Community at
Large Mourn the Loss of Dr Samuel Jacobson

Samuel G. Jacobson, MD, PhD, William C. Frayer Professor of Ophthalmology, served as director of the Center for Hereditary Retinal Degenerations, which he established at Scheie Eye Institute in 1995. Dr. Jacobson, in his 40+ year career in science and medicine, distinguished himself as a caring and compassionate physician, and a world-class scientist. He entered the field of inherited retinal diseases when clinical specialists were rare, there was little medical or scientific interest in genetic blindness, and there were no treatments. Over decades, he advanced understanding of the molecular mechanisms of these disorders. He was a pioneer in the application of gene-based and mechanism-driven therapies for diseases previously considered as incurable. During his tenure, he trained many clinicians currently working in the field of retinal degenerations, and he has been the recipient of major awards in visual science.  He is survived by his wife, Jean, daughter, Maxine, and brother, Fruman (Marian). Funeral services will be private. The family requests in lieu of flowers, donations be sent to the Eugenia R. Jacobson and Max M. Jacobson, M.D. Memorial Fund at the University of Illinois Foundation (visit give.uic.edu – Fund Number 12772236), or to the charity of your choice.

Cole Eye Institute – Genetics Fellowship

Cole Eye Institute:
Genetics Fellowship

Cole Eye Institute – Eye Genetics Fellowship

The Cole Eye Institute At Cleveland Clinic Is Pleased To Offer A One-Year Fellowship In Ophthalmic Genetics Starting In July 2023.

This one-time fellowship is open to senior residents who are finishing their training in June 2023 and available to start the fellowship in July/August 2023, and to other ophthalmologists who are completing fellowships in any ophthalmology subspecialty such as pediatric ophthalmology, medical and/or surgical retina, glaucoma, or neuro-ophthalmology. Ophthalmologists who are already in clinical practice are also eligible. The fellowship is supported by a grant from the American College of Medical Genetics and the recipient will receive a salary at the PGY5 level of training as well as other benefits identical to those of all other fellows at the Cleveland Clinic. The fellow must be eligible for a full Ohio license to practice medicine. Please contact Dr. Traboulsi directly for additional information at traboue@ccf.org . This unique fellowship experience has been planned to provide the candidate with an immersive, competency-directed curriculum and clinical experience so she/he is ready to take care of patients with genetically determined eye diseases and integrate this practice in academic institutions.

New for Ophthalmic Genetics and online NOW on Taylor & Francis Online

New for Ophthalmic Genetics and online:
NOW on Taylor & Francis Online

Case Report

Phenotypic expansion of KCNJ13-associated snowflake vitreoretinal degeneration
Noy Ashkenazy, Jesse D. Sengillo, Prashanth G. Iyer, Catherin I. Negron, Nicolas A. Yannuzzi & Audina M. Berrocal
Pages: 1-4 | DOI: 10.1080/13816810.2022.2149816

Isolated aniridia caused by a novel PAX6 heterozygous deletion mediated by multi-exon complex rearrangement
Aramis B. Torrefranca, Suzanne Marie Carmona, Alvina Pauline D. Santiago, Eva Cutiongco-Dela Paz & Michelle D. Lingao
Pages: 1-4 | DOI: 10.1080/13816810.2022.2144904

Acute intraoperative subgaleal hematoma associated with vitreoretinal surgery in a patient with Ehlers-Danlos Syndrome Type VI
Marissa M. Patel, Thomas A. Lazzarini, Joshua H. Uhr, Catherin I. Negron & Audina M. Berrocal
Pages: 1-2 | DOI: 10.1080/13816810.2022.2098988

Dual phenotype: co-occurring Leber congenital amaurosis and familial exudative vitreoretinopathy: a case report
Virginia Miraldi Utz, Jared J. Ebert, Diana S. Brightman, Brittany N. Simpson, Stefanie Benoit & Robert A. Sisk
Pages: 1-4 | DOI: 10.1080/13816810.2022.2090011

Retinopathy and optic atrophy in a case of COQ2-related primary coenzyme Q10 deficiency
Jeannette Y. Stallworth, David R. Blair, Anne Slavotinek, Anthony T. Moore, Jacque L. Duncan & Alejandra G. de Alba Campomanes
Pages: 1-5 | DOI: 10.1080/13816810.2022.2141792

Research Report

Effects of duration and number of symptoms on vision-related anxiety in patients with Inherited Retinal Diseases
Lilia T. Popova, Rebhi O. Abuzaitoun, Maria Fernanda Abalem, Chris A. Andrews, Alison M. Mondul, Gabrielle D. Lacy, David C. Musch & K. Thiran Jayasundera
Pages: 1-8 | DOI: 10.1080/13816810.2022.2144901

Next ISGEDR Meeting in São Paulo, Brazil – CUBO Save the date: July 6-8th, 2023

Next ISGEDR Meeting in São Paulo, Brazil – CUBO:
Save the date: July 6-8th, 2023

 

Next ISGEDR Meeting in São Paulo, Brazil – CUBO – Save the date: July 6-8th, 2023

Ophthalmic Genetics – FREE Subscription

The Journal is the official publication of ISGEDR and the OGSC. Members of ISGEDR receive a free subscription to the Journal and have access to all back issues.

Click here to visit the home page of Ophthalmic Genetics on the Informa Publisher website

You may need to request to join the ISGEDR group on LInkedIn to gain access to this page.

Follow ISGEDR on Twitter